Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,393 | -3,701 | -3,909 | 3,904 | -3,038 |
| Depreciation Amortization | 6 | 90 | N/A | 108 | 847 |
| Accounts receivable | N/A | -4 | -5 | -1 | N/A |
| Other Working Capital | 552 | 299 | -75 | 705 | -87 |
| Other Operating Activity | 1 | 90 | 491 | -6,993 | 1,121 |
| Operating Cash Flow | $-3,834 | $-3,225 | $-3,498 | $-2,278 | $-1,157 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 974 | -4,147 | 67 | 7,021 | N/A |
| Other Investing Activity | 0 | 0 | 20 | 172 | 39 |
| Investing Cash Flow | $974 | $-4,147 | $87 | $7,193 | $39 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2 | 54 |
| Debt Repayment | N/A | N/A | N/A | -2 | -35 |
| Common Stock Issued | 3,415 | N/A | 4,941 | N/A | 2,116 |
| Common Stock Repurchased | -173 | -471 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 3,794 | 0 |
| Financing Cash Flow | $3,242 | $-471 | $4,941 | $3,794 | $2,135 |
| Beginning Cash Position | 3,524 | 11,367 | 9,837 | 1,128 | 112 |
| End Cash Position | 3,906 | 3,524 | 11,367 | 9,837 | 1,128 |
| Net Cash Flow | $382 | $-7,843 | $1,530 | $8,709 | $1,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,834 | -3,225 | -3,498 | -2,278 | -1,157 |
| Free Cash Flow | -3,834 | -3,225 | -3,498 | -2,278 | -1,157 |